Swiss National Bank Imago Bio Sciences, Inc. Transaction History

Swiss National Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$15.03 - $35.96 $12,024 - $28,768	800 Added 2.52%	32,600 $1.17 Million
Q2 2022 Aug 09, 2022	BUY	$11.81 - $20.92 $47,240 - $83,680	4,000 Added 14.39%	31,800 $426,000
Q1 2022 May 09, 2022	BUY	$16.97 - $25.0 $33,940 - $50,000	2,000 Added 7.75%	27,800 $536,000
Q4 2021 Feb 08, 2022	BUY	$16.22 - $29.69 $418,475 - $766,002	25,800 New	25,800 $612,000

19.3K

Ticker IMGO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,741,600
Description
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.